Clinical Trials Browser

Phase 1/2 × Mesothelioma, Malignant × Lymphoid × Clear all

Mesothelioma, Malignant, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05598268 2022-10-28

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Phase 1/2 Unknown

74 enrolled

GastrointestinalLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Liver Neoplasms, Lung Neoplasms, Lymphoma

Clinical Trials

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.